Abstract
Anxiety affects over 260 million people worldwide. Benzodiazepines are a class of agents used in combination with other therapies for the management of anxiety. Lorazepam is a commonly prescribed benzodiazepine metabolized by uridine 5'-diphosphate-glucuronosyltransferases. Herein, we discuss recent findings regarding the pharmacogenetics of uridine 5'-diphosphate-glucuronosyltransferase 2B15 (UGT2B15), lorazepam, and its role in the treatment of anxiety.
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for freeCite
CITATION STYLE
APA
Ching, N. R., Alzghari, A. K., & Alzghari, S. K. (2018). The Relationship of UGT2B15 Pharmacogenetics and Lorazepam for Anxiety. Cureus. https://doi.org/10.7759/cureus.3133
Readers' Seniority
Readers' Discipline
